TRIM25 and acute myeloid leukemia: To study the impact of TRIM25 on the malignant progression of AML, we transfected TRIM25 siRNAs in Kasumi-1 cells with the highest TRIM25 expression to construct a TRIM25 knockdown cell model, and transfect TRIM25 in HL-60 cells with the lowest TRIM25 expression.